通过深度学习评估吸气相CT、呼气相CT及临床数据对慢性阻塞性肺疾病诊断与分期的累积增益
本回顾性研究纳入COPDGene I期队列8893例参与者,训练卷积神经网络利用单相或双相CT及临床数据预测肺功能并分期COPD。结果显示,吸气-呼气双相CT及临床数据的加入可提升COPD分期准确性,单相CT在提供临床数据时与双相CT准确性相当。
要点
- CNN预测肺功能与参考标准呈中度至良好一致性(ICC 0.66-0.79)。
- 加入临床数据可提升多数模型的一致性(ICC 0.70-0.85)及分期准确性。
- 单相CT联合临床数据时,GOLD分期准确性与双相CT相当。
核心结论
- 基于CNN的COPD诊断与分期,在提供与分期相关的临床数据时,单相CT与吸气-呼气双相CT准确性相当。
研究设计与样本
- 回顾性研究,纳入COPDGene I期队列8893例参与者(平均年龄59.6岁±9.0,53.3%为男性),使用2007年11月至2011年4月间的吸气相和呼气相肺部CT及肺功能检查。
诊断标准与关键数值
- CNN预测与参考标准肺功能测量的ICC为0.66-0.79,加入临床数据后为0.70-0.85(P ≤ .04),但吸气相CNN联合临床数据的FEV1/FVC(P = .35)及呼气相CNN联合临床数据的FEV1(P = .33)除外。
- 单相CNN对GOLD分期、±1期内分期及诊断的准确性为59.8%-84.1%(682-959/1140),ICC为0.68-0.70。
- 吸气-呼气双相CNN模型的准确性为60.0%-86.3%(684-984/1140),ICC为0.72。
- 加入临床数据后,单相CNN的ICC为0.72(P ≤ .001)、准确性为65.2%-85.8%(743-978/1140);双相CNN的ICC为0.77-0.78(P ≤ .001)、准确性为67.6%-88.0%(771-1003/1140),但呼气相CNN联合临床数据的GOLD分期ICC无变化(P = .08)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To measure the benefit of single-phase CT, inspiratory-expiratory CT, and clinical data for convolutional neural network (CNN)-based chronic obstructive pulmonary disease (COPD) staging. Materials and Methods This retrospective study included inspiratory and expiratory lung CT images and spirometry measurements acquired between November 2007 and April 2011 from 8893 participants (mean age, 59.6 years ± 9.0 [SD]; 53.3% [4738 of 8893] male) in the COPDGene phase I cohort (ClinicalTrials.gov: NCT00608764). CNNs were trained to predict spirometry measurements (forced expiratory volume in 1 second [FEV1], FEV1 percent predicted, and ratio of FEV1 to forced vital capacity [FEV1/FVC]) using clinical data and either single-phase or multiphase CT. Spirometry predictions were then used to predict Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage. Agreement between CNN-predicted and reference standard spirometry measurements and GOLD stage was assessed using intraclass correlation coefficient (ICC) and compared using bootstrapping. Accuracy for predicting GOLD stage, within-one GOLD stage, and GOLD 0 versus 1-4 was calculated. Results CNN-predicted and reference standard spirometry measurements showed moderate to good agreement (ICC, 0.66-0.79), which improved by inclusion of clinical data (ICC, 0.70-0.85; P ≤ .04), except for FEV1/FVC in the inspiratory-phase CNN model with clinical data (P = .35) and FEV1 in the expiratory-phase CNN model with clinical data (P = .33). Single-phase CNN accuracies for GOLD stage, within-one stage, and diagnosis ranged from 59.8% to 84.1% (682-959 of 1140), with moderate to good agreement (ICC, 0.68-0.70). Accuracies of CNN models using inspiratory and expiratory images ranged from 60.0% to 86.3% (684-984 of 1140), with moderate to good agreement (ICC, 0.72). Inclusion of clinical data improved agreement and accuracy for both the single-phase CNNs (ICC, 0.72; P ≤ .001; accuracy, 65.2%-85.8% [743-978 of 1140]) and inspiratory-expiratory CNNs (ICC, 0.77-0.78; P ≤ .001; accuracy, 67.6%-88.0% [771-1003 of 1140]), except expiratory CNN with clinical data (no change in GOLD stage ICC; P = .08). Conclusion CNN-based COPD diagnosis and staging using single-phase CT provides comparable accuracy with inspiratory-expiratory CT when provided clinical data relevant to staging. Keywords: Convolutional Neural Network, Chronic Obstructive Pulmonary Disease, CT, Severity Staging, Attention Map Supplemental material is available for this article. © RSNA, 2024.
引用
- Lee AN, Hsiao A, Hasenstab KA, et al. Evaluating the Cumulative Benefit of Inspiratory CT, Expiratory CT, and Clinical Data for COPD Diagnosis and Staging through Deep Learning. Radiol Cardiothorac Imaging. 2024. PMID: 39665633. doi:10.1148/ryct.240005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。